Sulfamethoxazole: Hydroxypropyl-β-cyclodextrin complex: Preparation and characterization

Journal of Pharmaceutical and Biomedical Analysis

Volumn 63, Issue , 2012, Pages 74-79

  Garnero, Claudia ^a   Aiassa, Virginia ^a   Longhi, Marcela ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Aggregation; Conductivity; Hydroxypropyl cyclodextrin; Solid state analysis; Sulfamethoxazole

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; SULFAMETHOXAZOLE;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; ISOTHERM; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID STATE; THERMOGRAVIMETRY; THERMOSTABILITY;

ANTI-INFECTIVE AGENTS; BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; EXCIPIENTS; FREEZE DRYING; MICROSCOPY, ELECTRON, SCANNING; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFAMETHOXAZOLE; TECHNOLOGY, PHARMACEUTICAL; THERMOGRAVIMETRY;

EID: 84858078482     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.01.011     Document Type: Article

References (28)

1. Loftsson T., Fridriksdottir H., Olafsdottir B., Gudmundsson O. Solubilization and stabilization of drugs through cyclodextrin complexation. Acta Pharm. Nord. 1991, 3:215-217.
2. Duchene D., Wouessidjewe D. Physiochemical characteristics and pharmaceutical uses of cyclodextrin derivatives. Part II. Pharm. Technol. 1990, 14:26-34.
3. Loftsson T., Brewster M. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 1996, 85:1017-1025.
4. Loftsson T. Effects of cyclodextrins on the chemical stability of drugs in aqueous solutions. Drug Stability 1995, 1:22-33.
5. Rajewski R., Stella V. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J. Pharm. Sci. 1996, 85:1142-1169.
6. Loftsson T., Masson M., Sigurdsson H. Cyclodextrins and drug permeability through semi-permeable cellophane membranes. Int. J. Pharm. 2002, 232:35-43.
7. Loftsson T., Masson M., Brewster M. Self-association of cyclodextrins and cyclodextrin complexes. J. Pharm. Sci. 2004, 93:1091-1099.
8. Messner M., Kurkov S.V., Jansook P., Loftsson T. Self-assembled cyclodextrin aggregates and nanoparticles. Int. J. Pharm. 2010, 387:199-208.
9. Nieto A., Borrull F., Marce R.M., Pocurull E.J. Selective extraction of sulfonamides, macrolides and other pharmaceuticals from sewage sludge by pressurized liquid extraction. J. Chromatogr. A 2007, 1174:125-131.
10. Granero G., Garnero C., Longhi M. The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Sci. 2003, 20:285-293.
11. Granero G., Maitre M.S., Garnero C., Longhi M. Synthesis, characterization and in vitro release studies of a new acetazolamide:HP-β-CD-TEA inclusion complex. Eur. J. Med. Chem. 2008, 43:464-470.
12. Zoppi A., Quevedo M., Delrivo A., Longhi M. Complexation of sulfonamides with β-cyclodextrin studied by experimental and theoretical methods. J. Pharm. Sci. 2010, 99:3166-3176.
13. Adsmond D.A., Grant D.J.W. Hydrogen bonding in sulphonamides. J. Pharm. Sci. 2001, 90:2058-2077.
14. López Martínez L., López de Alba P.L., de León Rodríguez L.M., Yepez Murrieta M.L. Simultaneous determination of binary mixtures of trimethoprim and sulfamethoxazole or sulphamethoxypyridazine by the bivariate calibration spectrophotometric method. J. Pharm. Biomed. Anal. 2002, 30:77-85.
15. Takasuka M., Nakai H. IR and Raman spectral and X-ray structural studies of polymorphic forms of sulfamethoxazole. Vib. Spectrosc. 2001, 25:197-204.
16. Muthu Prabhu A., Venkatesh G., Rajendiran N. Spectral characteristics of sulfa drugs: effect of solvents, pH and β-cyclodextrin. J. Solution Chem. 2010, 39:1061-1086.
17. Wu Y.Q., Li D.X., Li B.G., Wang J. Preparation of inclusion compound of β-cyclodextrin with sulfamethoxazole. J. Univ. Shangai Sci. Technol. 2007, 29:315-320.
18. Diez N.M., De La Peña A.M., García M.C.M., Gil D.B., Cañada Cañada F. Fluorimetric determination of sulphaguanidine and sulphamethoxazole by host-guest complexation in β-cyclodextrin and partial least squares calibration. J. Fluoresc. 2007, 17:309-318.
19. McDonald C., Faridah Solubilities of trimethoprim and sulfamethoxazole at various pH values and crystallization of trimethoprim from infusion fluids. J. Parenter. Sci. Technol. 1991, 45:147-151.
20. Pourmokhtar M., Jacobson G.A. Enhanced stability of sulfamethoxazole and trimethoprim against oxidation using hydroxypropyl-β-cyclodextrin. Pharmazie 2005, 60:837-839.
21. Granero G., Garnero C., Longhi M. Second derivative spectrophotometric determination of trimethoprim and sulfamethoxazole in the presence of hydroxypropyl-β-cyclodextrin (HP-β-CD). J. Pharm. Biomed. Anal. 2002, 29:51-59.
22. Higuchi T., Connors K.A. Phase-solubility techniques. Advances in Analytical Chemistry and Instrumentation 1965, 117-212. Wiley-Interscience, New York. C.N. Reilly (Ed.).
23. Funk O., Schwabe L., Fromming K. Freeze-dried preparations of ketoprofen and heptakis-(2,6-o-dimethyl)-β-cyclodextrin. Drug Dev. Ind. Pharm. 1994, 20:1957-1969.
24. Brewster M.E., Loftsson T.T. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 2007, 59:645-666.
25. Loftsson T., Guomundsdottir T., Fridriksdottir H. The influence of water-soluble polymers and pH on hydroxypropyl-β-cyclodextrin complexation of drugs. Drug Dev. Ind. Pharm. 1996, 22:401-405.
26. Garnero C., Zoppi A., Genovese D., Longhi M. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation. Carbohydr. Res. 2010, 345:2550-2556.
27. Yang S.S., Guillory J.K. Polymorphism in sulfonamides. J. Pharm. Sci. 1972, 61:26-40.
28. Fernandes N.S., da Silva Carvalho Filho M.A., Mendes R.A., Ionashiro M. Thermal decomposition of some chemotherapic substances. J. Braz. Chem. Soc. 1999, 10:459-462.